Role of MgSO4 in reducing dose requirement of PROPOFOL during Neurosurgical procedure.
Not Applicable
- Conditions
- Health Condition 1: null- ASA1 & ASA2
- Registration Number
- CTRI/2018/12/016673
- Lead Sponsor
- Department of anaesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
pt undergoing elective neurosurgery
ASA1 and ASA2
Exclusion Criteria
allergy to mgso4 or any other study drug,
pt taking any enzyme inducer or inhibitor drug,
pt refusal,
renal,hepatic or cardiovascular dysfunction,
atrioventricular conductance disturbances,
opioid or analgesic abuse,
pt on chronic treatment with CCB or Magnesium.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method total dose of propofol required during elective neurosurgeryTimepoint: 1,5,10,15,30,45,60,90,120 mins and at the end of surgery
- Secondary Outcome Measures
Name Time Method heart rate, SBP, DBP, MAP. SpO2, EtCO2, BIS,TOFTimepoint: 1,5,10,15,30,45,60,90,120 mins and at the end of surgery